Community-randomised controlled trial embedded in the Anishinaabek Cervical Cancer Screening Study: human papillomavirus self-sampling versus Papanicolaou cytology

被引:27
作者
Zehbe, Ingeborg [1 ,2 ,3 ]
Jackson, Robert [1 ,4 ]
Wood, Brianne [5 ]
Weaver, Bruce [3 ]
Escott, Nicholas [3 ,6 ]
Severini, Alberto [7 ]
Krajden, Mel [8 ]
Bishop, Lisa [2 ]
Morrisseau, Kyla [2 ]
Ogilvie, Gina [8 ,9 ]
Burchell, Ann N. [10 ,11 ]
Little, Julian [5 ]
机构
[1] Thunder Bay Reg Res Inst, Probe Dev & Biomarker Explorat, Thunder Bay, ON, Canada
[2] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada
[3] Northern Ontario Sch Med, Clin Sci, Thunder Bay, ON, Canada
[4] Lakehead Univ, Biotechnol Program, Thunder Bay, ON, Canada
[5] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada
[6] Thunder Bay Reg Hlth Sci Ctr, Dept Pathol & Lab Med, Thunder Bay, ON, Canada
[7] Publ Hlth Agcy Canada, Viral Exanthemata & STD Sect, Natl Microbiol Lab, Winnipeg, MB, Canada
[8] BC Ctr Dis Control, Vancouver, BC, Canada
[9] Univ British Columbia, Sch Populat & Publ Hlth, Fac Med, Vancouver, BC, Canada
[10] Ontario HIV Treatment Network, Toronto, ON, Canada
[11] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
TO-TREAT ANALYSIS; 1ST NATIONS; NEW-ZEALAND; WOMEN; HPV; STATEMENT; CANADA; INTERVENTION; INDIVIDUALS; AUSTRALIA;
D O I
10.1136/bmjopen-2016-011754
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The incidence of cervical cancer is up to 20-fold higher among First Nations women in Canada than the general population, probably due to lower participation in screening. Offering human papillomavirus (HPV) self-sampling in place of Papanicolaou (Pap) testing may eventually increase screening participation and reduce cervical cancer rates in this population. Design: A community-randomised controlled screening trial. Setting: First Nations communities in Northwest Ontario, Canada. Participants: Women aged between 25 and 69, living in Robinson Superior Treaty First Nations. The community was the unit of randomisation. Interventions: Women were asked to complete a questionnaire and have screening by HPV self-sampling (arm A) or Pap testing (arm B). Primary outcome measures: The number of women who participated in cervical screening. Randomisation: Community clusters were randomised to include approximately equivalent numbers of women in each arm. Results: 6 communities were randomised to arm A and 5 to arm B. One community withdrew, leaving 5 communities in each group (834 eligible women). Participation was <25%. Using clustered intention-to-treat (ITT) analysis, initial and cumulative averaged uptakes in arm A were 1.4-fold (20% vs 14.3%, p=0.628) and 1.3-fold (20.6% vs 16%, p=0.694) higher compared to arm B, respectively. Corresponding per protocol (PP) analysis indicates 2.2-fold (22.9% vs 10.6%, p=0.305) and 1.6-fold (22.9% vs 14.1%, p=0.448) higher uptakes in arm A compared to arm B. Screening uptake varied between communities (range 0-62.1%). Among women who completed a questionnaire (18.3% in arm A, 21.7% in arm B), the screening uptake was 1.8-fold (ITT; p=0.1132) or 3-fold (PP; p<0.01) higher in arm A versus arm B. Conclusions: Pap and HPV self-sampling were compared in a marginalised, Canadian population. Results indicated a preference for self-sampling. More research on how to reach underscreened Indigenous women is necessary.
引用
收藏
页数:11
相关论文
共 43 条
[1]   Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial [J].
Arrossi, Silvina ;
Thouyaret, Laura ;
Herrero, Rolando ;
Campanera, Alicia ;
Magdaleno, Adriana ;
Cuberli, Milca ;
Barletta, Paula ;
Laudi, Rosa ;
Orellana, Liliana .
LANCET GLOBAL HEALTH, 2015, 3 (02) :E85-E94
[2]  
Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832
[3]   Consort 2010 statement: extension to cluster randomised trials [J].
Campbell, Marion K. ;
Piaggio, Gilda ;
Elbourne, Diana R. ;
Altman, Douglas G. .
BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
[4]   CONSORT statement: extension to cluster randomised trials [J].
Campbell, MK ;
Elbourne, DR ;
Altman, DG .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7441) :702-708
[5]   SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials [J].
Chan, An-Wen ;
Tetzlaff, Jennifer M. ;
Altman, Douglas G. ;
Laupacis, Andreas ;
Gotzsche, Peter C. ;
Krleza-Jeric, Karmela ;
Hrobjartsson, Asbjorn ;
Mann, Howard ;
Dickersin, Kay ;
Berlin, Jesse A. ;
Dore, Caroline J. ;
Parulekar, Wendy R. ;
Summerskill, William S. M. ;
Groves, Trish ;
Schulz, Kenneth F. ;
Sox, Harold C. ;
Rockhold, Frank W. ;
Rennie, Drummond ;
Moher, David .
ANNALS OF INTERNAL MEDICINE, 2013, 158 (03) :200-+
[6]   SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials [J].
Chan, An-Wen ;
Tetzlaff, Jennifer M. ;
Gotzsche, Peter C. ;
Altman, Douglas G. ;
Mann, Howard ;
Berlin, Jesse A. ;
Dickersin, Kay ;
Hrobjartsson, Asbjorn ;
Schulz, Kenneth F. ;
Parulekar, Wendy R. ;
Krleza-Jeric, Karmela ;
Laupacis, Andreas ;
Moher, David .
BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
[7]  
Colquhoun A, 2010, CHRONIC DIS CAN, V30, P135
[8]   Randomizing patients by family practice: sample size estimation, intracluster correlation and data analysis [J].
Cosby, RH ;
Howard, M ;
Kaczorowski, J ;
Willan, AR ;
Sellors, JW .
FAMILY PRACTICE, 2003, 20 (01) :77-82
[9]  
DAVISON AC, 1997, BOOTSTRAP METHODS TH, pCH5
[10]  
Demers A, 2012, CMAJ, V18, P743